2 unknown, 1 completed. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Unknown 2, Completed 1 |
Follow Directly Observed Therapy: new trials by email Literature Review of Directly Observed Therapy trials Research Report on Directly Observed Therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Motor Function Efficacy of Pharmacological Treatments Targeting Energy Metabolism, in Parkinson's Patients Terazosin - Parkinson Disease, Gait Analysis | Phase 4 | Unknown | I.R.C.C.S. Fondazione Santa Lucia | 50 | 2023-12-01 | 2023-09-22 |
| Nocardia Cell Wall Skeleton for the Treatment of Diabetic Foot Ulcer Wounds Nocardia rubra Cell Wall Skeleton, Silver ions dressing - Diabetic Foot Ulcer, Therapy, Directly Observed | Phase 4 | Unknown | The Affiliated Hospital of Xuzhou Medical University | 116 | 2022-05-20 | 2022-05-10 |
| A Trial of Directly Observed and Long-term Varenicline Long-Term Varenicline, Short-Term Varenicline, Directly Observed Therapy - Tobacco Use Disorder, Opioid-use Disorder | Phase 4 | Completed | Albert Einstein College of Medicine | 243 | 2018-10-25 | 2024-08-30 |
Diabetic Foot (1) · Metabolic Diseases (1) · Opioid-Related Disorders (1) · Parkinson Disease (1) · Tobacco Use Disorder (1)
Behavior (3) · Health Behavior (3) · Medication Adherence (3) · Patient Acceptance of Health Care (3) · Patient Compliance (3) · Treatment Adherence and Compliance (3) · Basal Ganglia Diseases (1) · Brain Diseases (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Chemically-Induced Disorders (1) · Diabetes Complications (1) · Diabetes Mellitus (1) · Diabetic Angiopathies (1) · Diabetic Neuropathies (1)
Control Groups (1) · Lisosan G (1) · Terazosin (1) · Varenicline (1)
Albert Einstein College of Medicine (1) · I.R.C.C.S. Fondazione Santa Lucia (1) · The Affiliated Hospital of Xuzhou Medical University (1)
United States (1)
Antonella Peppe, MD, PhD (1) · Shadi Nahvi, MD, MS (1)
R01DA042813 (1)